USPTO launches COVID-19 Response Resource Center

Having trouble viewing this email? View it as a Web page.

USPTO Alert

USPTO-footer-graphic

USPTO launches COVID-19 Response Resource Center

The United States Patent and Trademark Office (USPTO) today launched the COVID-19 Response Resource Center to provide stakeholders and other interested parties with improved access to USPTO initiatives, programs, and other helpful intellectual property (IP)-related information regarding the COVID-19 outbreak.

“As it always does, our nation’s innovation community will play a crucial role in devising creative solutions to the ongoing pandemic,” said Andrei Iancu, Under Secretary of Commerce for Intellectual Property and Director of the USPTO. “The USPTO stands shoulder-to-shoulder with inventors and entrepreneurs and is working on a variety of measures to incentivize, protect, and disseminate COVID-19 related innovation. The COVID-19 Response Resource Center will provide inventors, entrepreneurs, and IP practitioners with a centralized destination to access information and assistance needed to meet the challenges of these times.”

The resource center allows users to easily view information on a number of critical initiatives to aid the public throughout the ongoing crisis, including the USPTO’s “Patents 4 Partnerships” IP marketplace platform and the COVID-19 Prioritized Examination Pilot Program for accelerating the evaluation of patent applications directed to COVID-19 related technologies. Information on trademark counterfeiting and consumer fraud, as well as updates on international developments related to the COVID-19 outbreak, are also available.

The resource center also includes links to the USPTO’s Pro Bono Program, information on voluntary early patent application publication, and resources for inventors and small businesses. The resource center will be updated on a continuing basis to incorporate new information, programs, and initiatives.

The USPTO invites the public to submit recommendations or suggestions for the USPTO to consider as it assists the IP community. Please email comments to COVIDcomments@uspto.gov